Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)

Represents 8th Consecutive Year of 20% or More Constant Currency Revenue Growth

...

Related Keywords

Massachusetts ,United States ,America ,Gregoryp Forlenza ,Jim Hollingshead ,Danielj Desalvo ,Insulet Corporation ,Diabetes Technology ,Company Classic Omnipod ,Drug Administration ,International Omnipod ,Exchange Commission ,Company Term Loan ,Year Financial Highlights ,Quarter Financial Highlights ,Freestyle Libre ,Chief Executive ,Customer Starts ,Insulin Delivery System ,Glycemic Outcomes Persist ,Very Young Children ,Insulin Delivery ,Operating Margin Guidance ,Eastern Time ,Investor Relations ,Omnipod Insulin Management System ,Looking Statement ,Convertible Senior Notes ,Annual Report ,Quarterly Reports ,Months Ended December ,Ended December ,Ending December ,Months Ending March ,Markets ,